Markdown source

Engineering Agency out of the Happy Path

Conference Context

Session Description

I spent ‘24 and ‘25 structuring the entire written history of biopharma - through drugs, trials, deals, etc. This was a ~500B token effort that translated into a production system now used by 19 of the 20 largest pharmas. We achieved PhD-level performance at scale with 99.95% accuracy over critical concepts. The hard parts were solving questions of domain and organizational “shape”. This involved identifying which critical concepts and which bundle of tasks were worth the organizational investment to automate. And the biggest spillover win wasn't actually about time savings, it was about refocusing scarce expert judgment on error exhaust - out of which falls potential high value roadmap. I'll walk through real examples and non-obvious, transferable wins. While the case example is in biopharma, the pattern applies to any business that relies on expert domain judgement to deliver differentiated value.

Media Evidence

No related AI Engineer channel video found yet.

Evidence Graph

This evidence graph is generated from currently linked source material: official schedule text, related video pages, cached transcripts, visible slide text, dense/reconstructed slide pages, and AI slide-classification audits.

Media Signals

No linked video, transcript, or slide source has been attached yet.

Agent Reading Notes

Use these signals to refine the synopsis, topic links, people/company context, and method notes. If a source is a related external video rather than an exact official recording, keep it framed as supporting evidence.

Transcript Status

No official session recording transcript was found by exact title match on the AI Engineer YouTube channel during this run.

People

Notes

Synthesis

Synthesized Breakdown

Engineering Agency out of the Happy Path ## Conference Context - Date/time: 2026-06-30 · 1:55pm-2:15pm - Track/room: AI Architects: Tokenmaxxing · Leadership 2 - Speaker(s): Matthew Jewkes - Session type/status: session · confirmed - Track: AI Architects: Tokenmaxxing - Room: Leadership 2 - Session type: session - Status: confirmed ## Session Description I spent ‘24 and ‘25 structuring the entire written history of biopharma - through drugs, trials, deals, etc. This was a ~500B token effort that translated into a production system now used by 19 of the 20 largest pharmas. We achieved PhD-level performance at scale with 99.95% accuracy over critical concepts. The hard parts were solving questions of domain and organizational “shape”.

Speaker And Company Context

Topics Covered

Derived Links And Source Material

Novel Concepts / Clever Methods

Evidence Boundary

This synthesis is based on the official schedule and linked source pages. It should be revisited when exact session recordings or transcript-backed secondary sources are available.